Back to search
Restrictive Chronic Lung Allograft Dysfunction
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Restrictive Chronic Lung Allograft Dysfunction trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Restrictive Chronic Lung Allograft Dysfunction trials you may qualify forThis study is for people who have had a lung transplant and developed a condition called chronic lung allograft dysfunction (CLAD), which is a type of chronic r…
Despite advances in lung transplantation, the median survival remains only 55% at 5 years. The main limitation to long term survival is the development of chron…
A controlled randomized, open-label, multi-centre study evaluating if an immunosuppressive protocol, based on ATG-induction, once daily tacrolimus-dose (Advagra…
While many patients experience benefits from transplant, complications such as infections and lung rejection may affect long term survival and quality of life.…